3',4'-Methylenedioxy-α-pyrrolidinobutiophenone

Synthetic stimulant drug

3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP) is a synthetic stimulant of the cathinone class. It is chemically related to pyrrolidinophenone derivatives and is known for its psychoactive effects. MDPBP is often encountered in the context of designer drugs and has been subject to legal control in various jurisdictions.

Chemical Structure and Properties

Chemical structure of MDPBP

MDPBP is characterized by the presence of a methylenedioxy group attached to the phenyl ring, which is a common feature in many psychoactive substances. The compound also contains a pyrrolidinyl group, which is responsible for its stimulant properties. The full chemical name is 1-(3,4-methylenedioxyphenyl)-2-(pyrrolidin-1-yl)butan-1-one.

Pharmacology

MDPBP acts as a central nervous system stimulant. It is believed to exert its effects primarily by inhibiting the reuptake of dopamine and norepinephrine, leading to increased concentrations of these neurotransmitters in the synaptic cleft. This mechanism is similar to that of other stimulants such as amphetamines and cocaine.

Effects and Usage

The effects of MDPBP are similar to those of other stimulant drugs, including increased alertness, euphoria, and enhanced physical performance. However, it can also lead to adverse effects such as anxiety, paranoia, and cardiovascular issues. Due to its potential for abuse and harmful effects, MDPBP is not approved for medical use.

Legal Status

MDPBP in powder form

MDPBP has been classified as a controlled substance in several countries due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting new psychoactive substances (NPS) or "legal highs."

Synthesis

The synthesis of MDPBP involves the reaction of 3,4-methylenedioxyphenyl-2-propanone with pyrrolidine and a butanone derivative. The process requires careful control of reaction conditions to ensure the desired product is obtained.

Health Risks

The use of MDPBP can lead to serious health risks, including cardiovascular complications, neurological effects, and potential for addiction. Users may experience tachycardia, hypertension, and hyperthermia. Long-term use can result in psychological dependence and cognitive deficits.

Related Pages

• Cathinone
• Pyrrolidinophenone
• Designer drug
• Stimulant